-
Real-World Evidence in Action: Assessing Drug-Drug Interactions to Drive Value-Based Decisions
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Pharmacogenetic Testing to Guide Treatment for Children With Asthma
Sep 9, 2025, 16:22 PM -
HTA League of Nations: Which Bodies Were Most Likely to Approve Submissions and for What Disease Areas?
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Assessment of Orphan Drugs in France: Key Insights from CEESP Reviews (2021-2024)
Sep 9, 2025, 16:22 PM -
How Do National Systems Take the JCA Into Account Navigating Specificities to Achieve Accelerated Patient Access?
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Linzagolix 200 mg Plus Add-back Therapy (Linzagolix+ABT) for Symptomatic Treatment of Endometriosis
Sep 9, 2025, 16:22 PM -
Uncertainties in Regulatory Benefit-Risk Decision Making for Innovative Anticancer Therapies: Preliminary Results From a 2011-2024 Review of Extensions of Indications
Sep 9, 2025, 16:22 PM -
The Estimation of Utility Weights From the Rett Syndrome Behavior Questionnaire
Sep 9, 2025, 16:22 PM -
Treatment Preferences in Adults With Chronic Spontaneous Urticaria Symptomatic on H1-Antihistamines in the Netherlands: Insights From CHOICE-CSU 2 Study
Sep 9, 2025, 16:22 PM -
Significant Burden of Chronic Obstructive Pulmonary Disease (COPD) on Health Status and Well-Being Persists Among Patients Experiencing One Severe or Two or More Moderate Exacerbations of COPD (ECOPD) and Their Caregivers (CGs)
Sep 9, 2025, 16:22 PM -
The Disease Burden of Systemic Sclerosis in the Russian Federation
Sep 9, 2025, 16:22 PM -
Implementing Coverage With Evidence Development for Medicines With Uncertain Clinical Benefit: Insights From the Netherlands
Sep 9, 2025, 16:22 PM -
Optimizing Colorectal Cancer Screening in the Czech Republic: Cost-Effectiveness of Lowering the Starting Age to 45 and Introducing an Upper Limit
Sep 9, 2025, 16:22 PM -
Clinical Efficacy and Safety of Targeted Therapies for HER2 Mutant Advanced or Metastatic Non-Small Cell Lung Cancer: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Costs of Breast Cancer Surgical Care in Newly Diagnosed Patients in 2015 and 2019: A French Nationwide Claims Database Study
Sep 9, 2025, 16:22 PM -
Cost Variation Across Lung-Cancer Diagnostic-Pathway Clusters: A Nationwide Real-World Analysis of 18,569 French Patients
Sep 9, 2025, 16:22 PM -
Enhancing Palliative Care in Intensive Care Units (EPIC) Trial Design of the Health Economic Substudy
Sep 9, 2025, 16:22 PM -
Cost Utility of Subcutaneous Methotrexate As a Second-Line Treatment for Moderate to Severe Rheumatoid Arthritis in the UK
Sep 9, 2025, 16:22 PM -
Lessons Learnt From PICO Exercise Developed by the Joint Clinical Assessment Subgroup for Etranacogene Dezaparvovec
Sep 9, 2025, 16:22 PM -
A Systematic Review (SR) and Network Meta-Analysis (NMA) of Cystic Fibrosis Transmembrane Conductance Receptor (CFTR) Modulator Therapies and Established Clinical Management (ECM) Using Percent Predicted Forced Expiratory Volume in One Second...
Sep 9, 2025, 16:22 PM
